肺癌放疗患者个体灌注与通气剂量反应差异研究
本研究纳入20例接受放疗的功能规避方案肺癌患者,于放疗前后行SPECT-CT通气和灌注扫描,计算接受≥20 Gy区域的相对变化及0-60 Gy区域的线性斜率。结果显示25%患者通气和灌注变化差异>35%,20-30%患者通气和灌注变化方向相反;放射科医生半定量评估也发现20%患者通气和灌注变化不同。结论提示通气和灌注剂量反应在部分患者中存在差异,预测临床结局时可能需要两者兼顾。
要点
- 肺癌放疗患者中约20-30%通气和灌注的剂量反应方向或幅度不一致,仅评估单一模式可能不够。
- 放疗前后通气和灌注变化差异>35%者占25%,提示个体内功能变化存在异质性。
- 放射科医生半定量功能缺陷评分可识别通气和灌注变化不一致的患者。
关键影像表现/征象
- 25%的患者通气和灌注放疗前后变化差异>35%。
- 20-30%的患者通气和灌注放疗前后变化方向相反。
- 放射科医生半定量评估显示20%的患者通气和灌注放疗前后变化不同。
临床应用与阅片要点
- 肺癌放疗功能规避计划及毒性预测时,宜同时参考通气和灌注功能成像,避免仅依赖单一模式。
- 阅片时注意通气和灌注变化方向不一致或幅度差异较大的患者,可能提示个体化剂量反应差异。
局限性
- 样本量较小(20例),结论需更大样本验证。
- 单中心前瞻性功能规避方案,可能存在选择偏倚。
- 采用SPECT-CT功能成像,空间分辨率有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Current ventilation and perfusion dose-response studies focus on single-modalities (ventilation or perfusion) and perform pulmonary-toxicity assessment related to radiotherapy on a population-based basis. This study aims at quantitative and clinical evaluation of intrapatient differences between ventilation and perfusion dose-responses among lung cancer patients treated with radiotherapy.
METHODS: 20 patients enrolled on a prospective functional avoidance protocol underwent single photon emission computed tomography-CT ventilation and perfusion scans pre- and post-radiotherapy. Relative changes in pre- to post-treatment ventilation and perfusion in lung regions receiving ≥20 Gy were calculated. In addition, the slopes of the linear fit to the relative ventilation and perfusion changes in regions receiving 0-60 Gy were calculated. A radiologist read and assigned a functional defect score to pre- and post-treatment ventilation/perfusion scans.
RESULTS: 25% of patients had a difference >35% between ventilation and perfusion pre- to post-treatment changes and 20-30% of patients had opposite directions for ventilation and perfusion pre- to post-treatment changes. Using a semi-quantitative scale, radiologist assessment showed that 20% of patients had different pre- to post-treatment ventilation changes when compared to pre- to post-treatment perfusion changes.
CONCLUSION: Our data showed that ventilation dose-response can differ from perfusion dose-response for 20-30% of patients. Therefore, when performing thoracic dose-response in cancer patients, it is insufficient to look at ventilation or perfusion alone; but rather both modes of functional imaging may be needed when predicting for clinical outcomes.
ADVANCES IN KNOWLEDGE: The significance of this study can be highlighted by the differences between the intrapatient dose-response assessments of this analysis compared to existing population-based dose-response analyses. Elucidating intrapatient ventilation and perfusion dose-response differences may be valuable in predicting pulmonary toxicity in lung cancer patients post-radiotherapy.
引用
- Forghani, Castillo, Castillo, et al. Is individual perfusion dose-response different than ventilation dose-response for lung cancer patients treated with radiotherapy? Br J Radiol. 2023. PMID: 36633096. doi:10.1259/bjr.20220119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。